Abstract
We studied the bactericidal capacity of the rat lung during the development of pneumococcal pneumonia. Pneumonia was produced in a lower lobe by the intrabronchial instillation of 10(4)Streptococcus pneumoniae cells in buffer. Lung bacterial counts progressively increased, reaching 10(7) per lung within 48 h, and the increase was associated with localized atelectasis and consolidation. Bacterial multiplication was inhibited with tetracycline at various intervals after infection, and the subsequent clearance of pneumococci was determined. Viable pneumococci were rapidly killed by lung defenses if bacterial multiplication was inhibited within 12 h of the onset of infection. No change occurred in the bacterial populationif tetracycline was delayed until 24 h after infection, indicating that pneumococcal killing by lung defenses had ceased. This effect could be reproduced with the addition of pneumococcal capsular polysaccharide to the inoculum, which produced a dose-related inhibition of pneumococcal clearance. The clearance of S. epidermidis was not impaired in the presence of pneumococcal pneumonia or by administration of exogenous capsular polysaccharide. These data indicate that pneumococcal pneumonia causes a marked impairment in lung antipneumococcal defenses within 24 h of the onset of infection. This acquired defect in antibacterial defenses may be due to the accumulation of pneumococcal capsular material in the lungs of infected animals.
MeSH Terms
Animals
Lung/immunology,microbiology,pathology
Male
Mice
Phagocytosis
Pneumonia, Pneumococcal/immunology,microbiology,pathology
Polysaccharides, Bacterial/pharmacology
Staphylococcus
Streptococcus pneumoniae/drug effects,growth & development
Tetracycline/pharmacology
Time Factors
Chemicals
Polysaccharides, Bacterial
Tetracycline
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ansfield M J
Woods D E
Johanson W G
References (23)
23 references, click to expand
-
Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses.
Ann Intern Med. 1976 Mar;84(3):254-60
PMID: 1259259
-
Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material.
J Clin Invest. 1976 Aug;58(2):271-5
PMID: 956366
-
An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery.
J Exp Med. 1956 Apr 1;103(4):499-508
PMID: 13306858
-
An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
J Exp Med. 1956 Apr 1;103(4):509-22
PMID: 13306859
-
THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.
J Exp Med. 1964 Jan 1;119:167-76
PMID: 14113111
-
A QUANTITATIVE STUDY OF THE DEPOSITION AND CLEARANCE OF BACTERIA IN THE MURINE LUNG.
J Clin Invest. 1964 Apr;43:759-68
PMID: 14149927
-
FACTORS INFLUENCING THE CLEARANCE OF BACTERIA BY THE LUNG.
J Clin Invest. 1964 Apr;43:769-76
PMID: 14149928
-
Host-parasite relationships in experimental pneumonia due to pneumococcus type III.
J Exp Med. 1950 Jul 1;92(1):85-100
PMID: 15422100
-
Pneumococcal type-associated variability in alternate complement pathway activation.
Infect Immun. 1975 Oct;12(4):772-8
PMID: 329
-
Bacterial growth in vivo. An important determinant of the pulmonary clearance of Diplococcus pneumoniae in rats.
J Clin Invest. 1974 May;53(5):1320-5
PMID: 4151066
-
Physical and immunologic properties of pneumococcal capsular polysaccharide produced during human infection.
J Immunol. 1974 Jun;112(6):2193-201
PMID: 4151109
-
The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung.
J Clin Invest. 1972 Aug;51(8):1989-98
PMID: 4341012
-
Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.
Am Rev Respir Dis. 1973 Oct;108(4):784-90
PMID: 4582433
-
Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia.
Infect Immun. 1972 Oct;6(4):431-7
PMID: 4628896
-
Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. II. Etiologic diagnosis of pneumococcal pneumonia.
J Lab Clin Med. 1973 May;81(5):778-86
PMID: 4698662
-
The effect of pulmonary edema on antibacterial defenses of the lung.
J Lab Clin Med. 1973 Oct;82(4):634-48
PMID: 4755437
-
Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.
J Clin Invest. 1974 Sep;54(3):519-28
PMID: 4853956
-
Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing.
N Engl J Med. 1970 Jan 15;282(3):123-8
PMID: 4982606
-
Microbioassay of antimicrobial agents.
Appl Microbiol. 1970 Apr;19(4):573-9
PMID: 4986725
-
The J. Burns Amberson Lecture--in defense of the lung.
Am Rev Respir Dis. 1970 Nov;102(5):691-703
PMID: 5475670
-
A method for quantitating intrapulmonary bacterial inactivation in individual animals.
J Lab Clin Med. 1966 Oct;68(4):669-77
PMID: 5923255
-
Determinants of lung bacterial clearance in normal mice.
J Clin Invest. 1976 Apr;57(4):811-7
PMID: 7575
-
An experimental analysis of the curative action of penicillin in acute bacterial infections. I. The relationship of bacterial growth rates to the antimicrobial effect of penicillin.
J Exp Med. 1956 Apr 1;103(4):487-98
PMID: 13306857